Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan Aida A. GuemeiJeff CottrellChris H. Takimoto Original Article 30 January 2001 Pages: 283 - 290
Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1 Merrill J. EgorinEleanor G. ZuhowskiJulie L. Eiseman Original Article 11 January 2001 Pages: 291 - 302
Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters Kunihiro KawanishiYasunari MiyagiTakafumi Kudo Original Article 09 December 2000 Pages: 303 - 308
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles Lia van ZuylenMats O. KarlssonAlex Sparreboom Original Article 16 February 2001 Pages: 309 - 318
In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac Shufeng ZhouJames W. PaxtonLai-Ming Ching Original Article 01 February 2001 Pages: 319 - 326
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy Robert J. Morgan JrTimothy SynoldJeff Longmate Original Article 08 December 2000 Pages: 327 - 332
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule D. FyfeC. PriceJ. Carmichael Original Article 28 February 2001 Pages: 333 - 337
The enhancement of riboflavin-mediated photo-oxidation of doxorubicin by histidine and urocanic acid Avner RamuMichelle M. MehtaAleksandar Aleksic Original Article 27 January 2001 Pages: 338 - 346
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A Mirte M. MalingréJos H. BeijnenJan H.M. Schellens Original Article 16 February 2001 Pages: 347 - 354
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential Paola Della TorreArturo Podestà Marco Brughera Original Article 17 February 2001 Pages: 355 - 360
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components Lucio TentoriIlaria PortarenaGrazia Graziani Original Article 07 February 2001 Pages: 361 - 369
Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study J. ShamashB. McLarenR.T.D. Oliver Original Article 21 February 2001 Pages: 370 - 372